Quick Takeaways
- PFM Health Sciences, LP filed SCHEDULE 13G/A for Werewolf Therapeutics, Inc. Common stock, par value $0.0001 per share (the "Shares") (HOWL).
- Disclosed ownership: 0.9%.
- Date of event: 30 Jun 2025.
PFM Health Sciences, LP - 30 Jun 2025 SCHEDULE 13G/A Report for Werewolf Therapeutics, Inc. Common stock, par value $0.0001 per share (the "Shares") (HOWL)
- Filing Manager
- PFM Health Sciences, LP
- Reporting Manager
- PFM Health Sciences, LP
- Symbol
- HOWL
- Shares outstanding
- 44,567,778 shares
- Disclosed Ownership
- 401,110 shares
- Ownership
- 0.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:48:35 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PFM Health Sciences, LP disclosed 0.9% ownership in Werewolf Therapeutics, Inc. Common stock, par value $0.0001 per share (the "Shares") (HOWL) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 14 Aug 2025, 16:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PFM Health Sciences, LP | 0.9% | 401,110 | 0 | 401,110 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| PFM Health Sciences GP, LLC | 0.9% | 401,110 | 0 | 401,110 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Partner Asset Management, LLC | 0.9% | 401,110 | 0 | 401,110 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Brian D. Grossman | 0.9% | 401,110 | 0 | 401,110 | /s/ Darren Mooney | Darren Mooney, attorney-in-fact* |